Market Engagement - Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS)

This is an advertisement for market testing only to gauge market interest which will influence future commissioning and procurement direction. This advertisement is issued under the Provider Selection Regime (PSR) of the Healthcare Services Regulations 2023. NHS Shropshire Telford and Wrekin Integrated Care Board ICB (STW ICB) has not decided at this point which PSR process best applies. STW ICB is not bound to comply with responses to this market testing and is also not bound to follow up with any procurement process.<br/><br/>NHS Shropshire Telford and Wrekin Integrated Care Board (STW ICB) has a requirement for a one-off consultant-led clinical review of existing patients with Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS). <br/><br/>STW ICB is seeking Expressions of Interest (EoIs) from potential providers that are suitably qualified and experienced in delivering ME/CFS services. <br/><br/>Any Provider wishing to express an interest in delivering this ME/CFS service in the Shropshire, Telford and Wrekin (STW) area should register their interest and complete the questionnaire on the Atamis Health Family eCommercial System at https://health-family.force.com/s/Welcome, no later than 12:00 noon on 24/04/2025.